130 related articles for article (PubMed ID: 15882607)
1. CCL3L1 dose and HIV-1 susceptibility.
Mackay CR
Trends Mol Med; 2005 May; 11(5):203-6. PubMed ID: 15882607
[TBL] [Abstract][Full Text] [Related]
2. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.
Gonzalez E; Kulkarni H; Bolivar H; Mangano A; Sanchez R; Catano G; Nibbs RJ; Freedman BI; Quinones MP; Bamshad MJ; Murthy KK; Rovin BH; Bradley W; Clark RA; Anderson SA; O'connell RJ; Agan BK; Ahuja SS; Bologna R; Sen L; Dolan MJ; Ahuja SK
Science; 2005 Mar; 307(5714):1434-40. PubMed ID: 15637236
[TBL] [Abstract][Full Text] [Related]
3. HIV-1/AIDS susceptibility and copy number variation in CCL3L1, a gene encoding a natural ligand for HIV-1 co-receptor CCR5.
Nakajima T; Kaur G; Mehra N; Kimura A
Cytogenet Genome Res; 2008; 123(1-4):156-60. PubMed ID: 19287150
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to HIV/AIDS: an individual characteristic we can measure?
Jülg B; Goebel FD
Infection; 2005 Jun; 33(3):160-2. PubMed ID: 15940420
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis.
McKinney C; Merriman ME; Chapman PT; Gow PJ; Harrison AA; Highton J; Jones PB; McLean L; O'Donnell JL; Pokorny V; Spellerberg M; Stamp LK; Willis J; Steer S; Merriman TR
Ann Rheum Dis; 2008 Mar; 67(3):409-13. PubMed ID: 17604289
[TBL] [Abstract][Full Text] [Related]
6. CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection.
Shao W; Tang J; Song W; Wang C; Li Y; Wilson CM; Kaslow RA
Genes Immun; 2007 Apr; 8(3):224-31. PubMed ID: 17330138
[TBL] [Abstract][Full Text] [Related]
7. Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C.
Grünhage F; Nattermann J; Gressner OA; Wasmuth HE; Hellerbrand C; Sauerbruch T; Spengler U; Lammert F
J Hepatol; 2010 Feb; 52(2):153-9. PubMed ID: 20044164
[TBL] [Abstract][Full Text] [Related]
8. Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands.
Arenzana-Seisdedos F; Parmentier M
Semin Immunol; 2006 Dec; 18(6):387-403. PubMed ID: 16978874
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of individual vulnerability to HIV infection of health care employees--hope or reality?].
Białecki P; Kurzawski M; Gańczak M; Białecka M
Przegl Lek; 2006; 63(9):797-9. PubMed ID: 17479873
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
Casoli C; Pilotti E; Bertazzoni U
AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
[TBL] [Abstract][Full Text] [Related]
11. CCL3L1 and HIV/AIDS susceptibility.
Bhattacharya T; Stanton J; Kim EY; Kunstman KJ; Phair JP; Jacobson LP; Wolinsky SM
Nat Med; 2009 Oct; 15(10):1112-5. PubMed ID: 19812561
[No Abstract] [Full Text] [Related]
12. CCL3L1 and HIV/AIDS susceptibility.
Urban TJ; Weintrob AC; Fellay J; Colombo S; Shianna KV; Gumbs C; Rotger M; Pelak K; Dang KK; Detels R; Martinson JJ; O'Brien SJ; Letvin NL; McMichael AJ; Haynes BF; Carrington M; Telenti A; Michael NL; Goldstein DB
Nat Med; 2009 Oct; 15(10):1110-2. PubMed ID: 19812560
[No Abstract] [Full Text] [Related]
13. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.
Dolan MJ; Kulkarni H; Camargo JF; He W; Smith A; Anaya JM; Miura T; Hecht FM; Mamtani M; Pereyra F; Marconi V; Mangano A; Sen L; Bologna R; Clark RA; Anderson SA; Delmar J; O'Connell RJ; Lloyd A; Martin J; Ahuja SS; Agan BK; Walker BD; Deeks SG; Ahuja SK
Nat Immunol; 2007 Dec; 8(12):1324-36. PubMed ID: 17952079
[TBL] [Abstract][Full Text] [Related]
14. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
[TBL] [Abstract][Full Text] [Related]
15. Identification of new variants within the two functional genes CCL3 and CCL3L encoding the CCL3 (MIP-1alpha) chemokine: implications for HIV-1 infection.
Paximadis M; Mohanlal N; Gray GE; Kuhn L; Tiemessen CT
Int J Immunogenet; 2009 Feb; 36(1):21-32. PubMed ID: 19055602
[TBL] [Abstract][Full Text] [Related]
16. Population-specific profiling of CCL3L1 copy number of the three major ethnic groups in Malaysia and the implication on HIV susceptibility.
Mohamad Isa II; Jamaluddin J; Achim NH; Abubakar S
Gene; 2020 Sep; 754():144821. PubMed ID: 32497559
[TBL] [Abstract][Full Text] [Related]
17. Gene copy number regulates the production of the human chemokine CCL3-L1.
Townson JR; Barcellos LF; Nibbs RJ
Eur J Immunol; 2002 Oct; 32(10):3016-26. PubMed ID: 12355456
[TBL] [Abstract][Full Text] [Related]
18. Genetic basis of HIV-1 resistance and susceptibility: an approach to understand correlation between human genes and HIV-1 infection.
Kumar V; Prakash O; Manpreet S; Sumedh G; Medhi B
Indian J Exp Biol; 2006 Sep; 44(9):683-92. PubMed ID: 16999022
[TBL] [Abstract][Full Text] [Related]
19. HIV/AIDS. HIV: experiencing the pressures of modern life.
Nolan D; James I; Mallal S
Science; 2005 Mar; 307(5714):1422-4. PubMed ID: 15746416
[No Abstract] [Full Text] [Related]
20. CCL3L1 copy number variation and susceptibility to HIV-1 infection: a meta-analysis.
Liu S; Yao L; Ding D; Zhu H
PLoS One; 2010 Dec; 5(12):e15778. PubMed ID: 21209899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
